Cargando…

Preventing Developmental Origins of Cardiovascular Disease: Hydrogen Sulfide as a Potential Target?

The cardiovascular system can be programmed by a diversity of early-life insults, leading to cardiovascular disease (CVD) in adulthood. This notion is now termed developmental origins of health and disease (DOHaD). Emerging evidence indicates hydrogen sulfide (H(2)S), a crucial regulator of cardiova...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chien-Ning, Tain, You-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914659/
https://www.ncbi.nlm.nih.gov/pubmed/33562763
http://dx.doi.org/10.3390/antiox10020247
Descripción
Sumario:The cardiovascular system can be programmed by a diversity of early-life insults, leading to cardiovascular disease (CVD) in adulthood. This notion is now termed developmental origins of health and disease (DOHaD). Emerging evidence indicates hydrogen sulfide (H(2)S), a crucial regulator of cardiovascular homeostasis, plays a pathogenetic role in CVD of developmental origins. Conversely, early H(2)S-based interventions have proved beneficial in preventing adult-onset CVD in animal studies via reversing programming processes by so-called reprogramming. The focus of this review will first summarize the current knowledge on H(2)S implicated in cardiovascular programming. This will be followed by supporting evidence for the links between H(2)S signaling and underlying mechanisms of cardiovascular programming, such as oxidative stress, nitric oxide deficiency, dysregulated nutrient-sensing signals, activation of the renin–angiotensin system, and gut microbiota dysbiosis. It will also provide an overview from animal models regarding how H(2)S-based reprogramming interventions, such as precursors of H(2)S and H(2)S donors, may prevent CVD of developmental origins. A better understanding of cardiovascular programming and recent advances in H(2)S-based interventions might provide the answers to bring down the global burden of CVD.